"The US Food and Drug Administration (FDA) has approved the long-acting muscarinic antagonist tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for long-term maintenance treatment of asthma in people aged 12 years and older, accor"...
Additional Lufyllin Information
Report Problems to the Food and Drug Administration
Allergies & Asthma
Improve treatments & prevent attacks.